Biotechnology Patents

We have substantial experience with biotechnology and pharmaceutical patents. One of the biggest challenges is obtaining and presenting meaningful clinic data to establish that the invention has been "reduced to practice." A compound that demonstrates efficacy against skin cancer might not be a viable therapeutic for breast cancer.

Patent examiners frequently attempt to narrow claims to only the ailments which have been tested in clinical settings asserting that results cannot be extrapolated due to the "unpredictable nature" of the biological arts. Our office has substantial experience in traversing these types of rejections.

Inexperienced patent attorneys might simply agree to an allowance of narrow claims without carefully considering the implications. If the compound or diagnostic is a potential blockbluster, then such missteps may cost the company millions of dollars in lost sales.